BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15524322)

  • 1. Expression, bioactivity, and clinical assessment of recombinant feline erythropoietin.
    Randolph JE; Scarlett JM; Stokol T; Saunders KM; MacLeod JN
    Am J Vet Res; 2004 Oct; 65(10):1355-66. PubMed ID: 15524322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of recombinant canine erythropoietin in dogs with anemia of chronic renal failure and dogs with recombinant human erythropoietin-induced red cell aplasia.
    Randolph JE; Scarlett J; Stokol T; MacLeod JN
    J Vet Intern Med; 2004; 18(1):81-91. PubMed ID: 14765736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lentiviral gene therapy strategy for the in vitro production of feline erythropoietin.
    Vapniarsky N; Lame M; McDonnel S; Murphy B
    PLoS One; 2012; 7(9):e45099. PubMed ID: 23028782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of darbepoetin to stimulate erythropoiesis in anemia of chronic kidney disease in cats: 25 cases.
    Chalhoub S; Langston CE; Farrelly J
    J Vet Intern Med; 2012; 26(2):363-9. PubMed ID: 22296687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and bioactivity of recombinant canine erythropoietin.
    MacLeod JN; Tetreault JW; Lorschy KA; Gu DN
    Am J Vet Res; 1998 Sep; 59(9):1144-8. PubMed ID: 9736393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient and stable transfection of Chinese hamster ovary cells with the recombinant feline erythropoietin gene and expression, purification, and biological activity of feline erythropoietin protein.
    Baldwin SL; Powell TD; Wonderling RS; Keiser KC; Morales T; Hunter S; McDermott M; Radecki SV; Milhausen MJ
    Am J Vet Res; 2003 Dec; 64(12):1465-71. PubMed ID: 14672421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant erythropoietin used to treat a cat with anemia caused by chronic renal failure.
    Henry PA
    Can Vet J; 1994 Jun; 35(6):375. PubMed ID: 8069840
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector.
    Beall CJ; Phipps AJ; Mathes LE; Stromberg P; Johnson PR
    Gene Ther; 2000 Mar; 7(6):534-9. PubMed ID: 10757028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia of renal disease: what it is, what to do and what's new.
    Chalhoub S; Langston C; Eatroff A
    J Feline Med Surg; 2011 Sep; 13(9):629-40. PubMed ID: 21872790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs.
    Randolph JF; Stokol T; Scarlett JM; MacLeod JN
    Am J Vet Res; 1999 May; 60(5):636-42. PubMed ID: 10328437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats.
    Arai M; Darman J; Lewis A; Yamamoto JK
    Vet Immunol Immunopathol; 2000 Nov; 77(1-2):71-92. PubMed ID: 11068067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative studies of erythropoiesis in the clinically normal, phlebotomized, and feline leukemia virus-infected cat.
    Wardrop KJ; Kramer JW; Abkowitz JL; Clemons G; Adamson JW
    Am J Vet Res; 1986 Oct; 47(10):2274-7. PubMed ID: 3022625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin fails to reverse the anemia in mice continuously exposed to tumor necrosis factor-alpha in vivo.
    Clibon U; Bonewald L; Caro J; Roodman GD
    Exp Hematol; 1990 Jun; 18(5):438-41. PubMed ID: 2338132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of erythropoietin in cats treated with a recombinant adeno-associated viral vector.
    Walker MC; Mandell TC; Crawford PC; Simon GG; Cahill KS; Fernandes PJ; MacLeod JN; Byrne BJ; Levy JK
    Am J Vet Res; 2005 Mar; 66(3):450-6. PubMed ID: 15822590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and management of anemia in chronic progressive renal failure.
    Cowgill LD
    Semin Vet Med Surg Small Anim; 1992 Aug; 7(3):175-82. PubMed ID: 1410849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of anemia associated with chronic renal failure by recombinant human erythropoietin treatment in ICR-derived glomerulonephritis (ICGN) mice.
    Yamaguchi-Yamada M; Manabe N; Goto Y; Anan S; Miyamoto K; Miyamoto Y; Nagao M; Yamamoto Y; Ogura A
    J Vet Med Sci; 2004 Jul; 66(7):883-6. PubMed ID: 15297765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia of chronic renal failure: characterization in the mouse and correction with human recombinant erythropoietin.
    Zhang F; Gagnon RF; Richards GK; Brox AG
    Nephron; 1996; 72(4):654-61. PubMed ID: 8730437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythroid hypoplasia and anemia following administration of recombinant human erythropoietin to two horses.
    Piercy RJ; Swardson CJ; Hinchcliff KW
    J Am Vet Med Assoc; 1998 Jan; 212(2):244-7. PubMed ID: 9448829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus-vectored erythropoietin gene therapy for anemia in cats with chronic kidney disease.
    Vaden SL; Kendall AR; Foster JD; New HL; Eagleson JS; May JL; Traas AM; Wilson MJ; McIntyre BH; Hinderer CJ; Olenick LK; Wilson JM
    J Vet Intern Med; 2023; 37(6):2200-2210. PubMed ID: 37847024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.